These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1822361)

  • 1. Interleukin 2-activated killer cells do not mediate autologous thyrocyte lysis in autoimmune thyroid disease in vitro.
    Matsubayashi S; Akasu F; Kasuga Y; Jamieson C; Volpé R
    Thyroid; 1991; 1(2):151-6. PubMed ID: 1822361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.
    Mariotti S; Caturegli P; Barbesino G; Marinò M; Del Prete GF; Chiovato L; Tonacchera M; De Carli M; Pinchera A
    Clin Endocrinol (Oxf); 1992 Nov; 37(5):415-22. PubMed ID: 1486691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic activity of interleukin-2 (IL-2) activated killer cells toward thyroid epithelial cells.
    Migita K; Eguchi K; Tezuka H; Otsubo T; Kawakami A; Nakao H; Ueki Y; Shimomura C; Matsunaga M; Ishikawa N
    Clin Exp Immunol; 1989 Aug; 77(2):196-201. PubMed ID: 2505957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
    Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
    J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and functional analysis at the clonal level of infiltrating T lymphocytes in papillary carcinoma of the thyroid: prevalence of cytolytic T cells with natural killer-like or lymphokine-activated killer activity.
    Bagnasco M; Venuti D; Paolieri F; Torre G; Ferrini S; Canonica GW
    J Clin Endocrinol Metab; 1989 Oct; 69(4):832-6. PubMed ID: 2789232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
    Solerte SB; Precerutti S; Gazzaruso C; Locatelli E; Zamboni M; Schifino N; Bonacasa R; Rondanelli M; Taccani D; Ferrari E; Fioravanti M
    Eur J Endocrinol; 2005 May; 152(5):703-12. PubMed ID: 15879355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease.
    Iwatani Y; Gerstein HC; Iitaka M; Row VV; Volpé R
    J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Killer cell activity and antibody-dependent cell-mediated cytotoxicity are normal in Hashimoto's disease.
    Sack J; Baker JR; Weetman AP; Wartofsky L; Burman KD
    J Clin Endocrinol Metab; 1986 May; 62(5):1059-64. PubMed ID: 3754262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
    Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
    Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of autoimmune hypothyroidism induced by lymphokine-activated killer (LAK) cell therapy: in vitro inhibition of human thyroid function by interleukin-2 in the presence of autologous intrathyroidal lymphocytes.
    Sato K; Yamazaki K; Shizume K; Yamakawa Y; Satoh T; Demura H; Kanaji Y; Obara T; Fujimoto Y; Aiba M
    Thyroid; 1993; 3(3):179-88. PubMed ID: 8257856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis.
    Del Prete GF; Vercelli D; Tiri A; Maggi E; Mariotti S; Pinchera A; Ricci M; Romagnani S
    Clin Exp Immunol; 1986 Jul; 65(1):140-7. PubMed ID: 3024884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease.
    Bogner U; Schleusener H; Wall JR
    J Clin Endocrinol Metab; 1984 Oct; 59(4):734-8. PubMed ID: 6548225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional activity of human thyrocytes in diffuse toxic goiter, autoimmune thyroiditis and thyroid nodules using nucleolar silver staining].
    Mamaev NN; Grineva EN; Laevskaia ND; Blagosklonnaia IaV
    Arkh Patol; 1994; 56(2):58-62. PubMed ID: 8037597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of interleukin-2 on suppressor T lymphocytes in autoimmune thyroid disease.
    Yoshikawa N; Morita T; Arreaza G; Resetkova E; Mukuta T; Volpé R
    Clin Invest Med; 1995 Apr; 18(2):91-8. PubMed ID: 7788961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced production of gamma-interferon by thyroid-derived T cell clones from patients with Hashimoto's thyroiditis.
    Del Prete GF; Tiri A; Mariotti S; Pinchera A; Ricci M; Romagnani S
    Clin Exp Immunol; 1987 Aug; 69(2):323-31. PubMed ID: 3115656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nontoxic nodular goiter and papillary thyroid carcinoma are not associated with peripheral blood lymphocyte sensitization to thyroid cells.
    Aguayo J; Sakatsume Y; Jamieson C; Row VV; Volpé R
    J Clin Endocrinol Metab; 1989 Jan; 68(1):145-9. PubMed ID: 2462573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease.
    Fisfalen ME; DeGroot LJ; Quintans J; Franklin WA; Soltani K
    J Clin Endocrinol Metab; 1988 Apr; 66(4):776-84. PubMed ID: 3257970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
    Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R
    J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease.
    O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL
    J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.